Pharmaceutical Unit Dose Packaging Market Size, Share, & COVID-19 Impact Analysis By Material (Plastic, Glass, Paper & Paperboard, and Metal), By Product Type (Ampoules, Bliters, Vials, Syringes & Cartridges, and Others), and By End User (Diabetes, Respiratory Therapy, Wound Care, Ophthalmic, Injectable, and Others), Regional Forecast, 2024-2032

The call for a safe and effective way for hospital staff to allocate medication led to the development of unit dose packaging. In a world where so many people take prescription medications daily, it is advantageous for patients to have their medications pre-packaged in unit doses, fuelling the growth of pharmaceutical unit dose packaging. Unit dose packaging protects the medicine from contamination, provides better patient service through pre-measured doses, and increases staff and patient safety. Thus, the benefits of unit dose packaging contribute to this market's growth.

• For instance, according to the Pan American Health Organization, non-communicable disease kills 41 million people every year globally, and in the U.S. 5.5 million deaths occur by NCDs. The rising diseases and deaths caused by diseases have increased the demand for medication and thus accelerated the growth of the pharmaceutical unit dose packaging market.

The unit dose packaging offers several advantages to the patients, such as it lets them know exactly how many medications to take. It also helps patients properly use medication and therefore have a proper healing process. Moreover, unit dose packaging reduces unnecessary costs to the patients, thus thriving the growth of this market. The rising number of diseases and the use of vaccination for their cure has increased and led to a surge in the number of vials and ampoules as they provide safety and are easy to handle, accelerating the growth of the pharmaceutical unit dose packaging market.

The increasing use of plastic in unit dose packaging is restricting the growth of this market as many nations ban single-use plastic and have strict legislation regarding its use and recycling process. However, the surging use of aluminum in the unit dose packaging is accelerating the growth of this market.

IMPACT OF COVID-19 ON THE PHARMACEUTICAL UNIT DOSE PACKAGING MARKET

The pandemic led to the downfall of many businesses and economies, however it also provided high-growth opportunities to the pharmaceutical and medical industry. Every nation was struggling with the outbreak of COVID-19 until the development of the vaccines, and that has led to the immense growth of the pharmaceutical unit dose packaging market. The social distancing led to an increase in the unit dose packages as doctors were avoiding contact. The pharmaceutical unit dose packaging is still growing due to the growing number of diseases, and changes in eating patterns and lifestyle are the primary reason for diseases.

SEGMENTATION

KEY INSIGHTS

• The report will cover the following key insights:


• Recent Advancements in the Pharmaceutical Unit Dose Packaging Market


• Key Industry Trends


• Regulatory Landscape for the Pharmaceutical Unit Dose Packaging Market


• Key Industry Developments (Mergers, Acquisitions, and Partnerships)


• Impact of COVID-19 on the Market

ANALYSIS BY MATERIAL

Based on material, the market is segmented into plastic, glass, paper & paperboard, and metal. Plastic is the dominating segment of the pharmaceutical unit dose packaging market. Plastic provides exceptional barrier properties to the content stored in it. The non-reactive properties of the plastic with the solutions and chemicals enhance this segment's growth.

ANALYSIS BY PRODUCT TYPE

Based on product type, the market is segmented into ampoules, blisters, vials, syringes & cartridges, and others. Vials hold the largest share in the pharmaceutical unit dose packaging market. Vials are best suitable to store stable chemicals and can store medicines for a longer period, leading to the growth of this segment.

ANALYSIS BY END USER

Based on end user, the market is segmented into diabetes, respiratory therapy, wound care, ophthalmic, injectable, and others. Diabetes is the dominating segment of the pharmaceutical unit dose packaging market. The world has seen many diabetic patients in the last decades. People with diabetes must inject insulin on a daily or weekly basis and have to take multiple medicines. Thus the increasing number of diabetic patients has led to an increase in the number of medications and led to the growth of this segment.

REGIONAL ANALYSIS

To gain extensive insights into the market, Request for Customization

The pharmaceutical unit dose packaging market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the leading region of the pharmaceutical unit dose packaging market. The already-developed pharmaceutical industry and continuous innovations are contributing to the growth of this region. Asia Pacific is the second largest pharmaceutical unit dose packaging region. The presence of growing economies such as China and India with high investment in the pharmaceutical industry coupled with the rising population and disposable income is bolstering this region’s growth. The European region is growing significantly due to a high geriatric population. The Latin America market will witness moderate growth. The increasing health awareness among the people is thriving the growth of this region. The Middle East & Africa region is forecasted to grow steadily. The increase in the non-communicable disease in this region is accelerating the growth of the pharmaceutical unit dose packaging market.

KEY PLAYERS COVERED

The report will include profiles of key players such as Gerresheimer AG, West Pharmaceuticals Services, Inc., Amcor Plc, Stevanato Group S.p.a., Klockner Pentaplast Group, Nipro Corporation, Catalent Inc., Becton, Dickinson and Company, Adelphi Healthcare Packaging, Pacific Vial Manufacturing Inc., Innovative Pharmacy Packaging Corporation Inc., Alfipa, FlexiPack ak, among others.

KEY INDUSTRY DEVELOPMENTS:

• April 2022 - Huhtamaki launched mono material blister lidding named Push Tab. The blister lid is made of PET to increase the recyclability of the packaging and make it sustainable. The blister lid has been designed to meet the safety demands of highly regulated healthcare and pharmaceutical packaging.


• January 2022 - Gerresheimer expanded production capacity by producing USD 150 million injection glass vials annually. Gerresheimer is already one of the largest manufacturers of the products required for vaccination campaigns, and this expansion in production capacity will increase the market hold of the company.


• October 2019 - Romaco launched push packs made of recyclable polyolefin, the first recyclable unit dose packaging. The push packs are used to store solid drug products.